Carnegie acted as sole global co-ordinator and joint bookrunner in the directed share issue of 1,200,000 new shares at a subscription price of SEK 0,506 per share.
Flerie is an active long-term life science investor, with a broad and diversified portfolio of innovative companies based on pioneering science.